Bertelsmann Next is a corporate venture capital investment unit associated with Bertelsmann. It has seed-stage investment activity in the United States, including exposure to AI-enabled pharmaceutical supply-chain and compliance technology. The firm is relevant for founders building in AI and machine learning, pharmaceuticals, and supply chain where a corporate strategic investor is a fit.